Differential Expression of Pancreatitis-Associated Protein and Thrombospondins in Arterial versus Venous Tissues

Background/Aims: Arteries and veins modulate cardiovascular homeostasis and contribute to hypertension pathogenesis. Functional differences between arteries and veins are based upon differences in gene expression. To better characterize these expression patterns, and to identify candidate genes that could be manipulated selectively in the venous system, we performed whole genome expression profiling of arteries and veins. Methods: We used the CodeLink platform and the major artery (thoracic aorta) and vein (caudal vena cava) of the rat. Results: The most prominent difference was pancreatitis-associated protein (PAP1), expressed 64-fold higher in vena cava versus aorta. Expression of mRNA for thrombospondins (TSP-1, TSP-4) was greater than 5-fold higher in veins versus arteries. Higher mRNA expression of TSP-1, TSP-2, TSP-4 and PAP1 in vena cava versus aorta was confirmed by PCR. Immunohistochemical analysis of tissue sections qualitatively confirmed a higher expression of these proteins in vena cava versus aorta. Conclusion: This is the first gene array study of adult rat arterial and venous tissues, and also the first study to report differences in inflammatory genes between arteries and veins. Data from these studies may provide novel insights into the genetic basis for functional differences between arteries and veins in health and disease.

[1]  Josephine C. Adams,et al.  The thrombospondins. , 2011, Cold Spring Harbor perspectives in biology.

[2]  A. Pries,et al.  Differential expression of VEGFA, TIE2, and ANG2 but not ADAMTS1 in rat mesenteric microvascular arteries and veins. , 2009, Physiological research.

[3]  M. Zenilman,et al.  Small-Interference RNA Gene Knockdown of Pancreatitis-Associated Proteins in Rat Acute Pancreatitis , 2008, Pancreas.

[4]  T. Lüscher,et al.  Prothrombotic Gene Expression Profile in Vascular Smooth Muscle Cells of Human Saphenous Vein, but Not Internal Mammary Artery , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[5]  L. Liaw,et al.  Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[6]  R. Dietz,et al.  Vascular Endothelial Cell–Specific NF-&kgr;B Suppression Attenuates Hypertension-Induced Renal Damage , 2007, Circulation research.

[7]  Sanne Kuijper,et al.  Regulation of angiogenesis by Eph-ephrin interactions. , 2007, Trends in cardiovascular medicine.

[8]  M. Iruela-Arispe,et al.  Notch signaling in blood vessels: who is talking to whom about what? , 2007, Circulation research.

[9]  C. Rondelli,et al.  Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. , 2007, American journal of physiology. Heart and circulatory physiology.

[10]  R. Klein,et al.  Bidirectional Eph-ephrin signaling during axon guidance. , 2007, Trends in cell biology.

[11]  P. Bornstein,et al.  Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice. , 2007, Journal of the American Society of Nephrology : JASN.

[12]  Fredrik Lanner,et al.  Functional Arterial and Venous Fate Is Determined by Graded VEGF Signaling and Notch Status During Embryonic Stem Cell Differentiation , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[13]  J. Yamashita,et al.  Differentiation of arterial, venous, and lymphatic endothelial cells from vascular progenitors. , 2007, Trends in cardiovascular medicine.

[14]  J. Iovanna,et al.  Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine. , 2007, World journal of gastroenterology.

[15]  A. Foussat,et al.  Interactions between CD47 and Thrombospondin Reduce Inflammation , 2007 .

[16]  K. Chatila,et al.  The role of the thrombospondins in healing myocardial infarcts. , 2007, Cardiovascular & hematological agents in medicinal chemistry.

[17]  R. Korbut,et al.  Adipocytokines - novel link between inflammation and vascular function? , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[18]  M. Iruela-Arispe,et al.  ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2 , 2006, The EMBO journal.

[19]  N. Seyfried,et al.  Versican-thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cells , 2006, Journal of Cell Science.

[20]  G. Laufer,et al.  In vivo (animal) models of vein graft disease. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  Thomas Schachner,et al.  Pharmacologic inhibition of vein graft neointimal hyperplasia. , 2006, The Journal of thoracic and cardiovascular surgery.

[22]  Daniel Closa,et al.  Pancreatitis-Associated Protein I Suppresses NF-κB Activation through a JAK/STAT-Mediated Mechanism in Epithelial Cells1 , 2006, The Journal of Immunology.

[23]  A. Tsalenko,et al.  Differences in Vascular Bed Disease Susceptibility Reflect Differences in Gene Expression Response to Atherogenic Stimuli , 2006, Circulation research.

[24]  Andrea J. Moore,et al.  Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization , 2006, Thrombosis and Haemostasis.

[25]  P. Tsao,et al.  Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Gaynor,et al.  Shear stress and pressure modulate saphenous vein remodeling ex vivo. , 2005, Journal of biomechanics.

[27]  David J. Anderson,et al.  Isolation of arterial‐specific genes by subtractive hybridization reveals molecular heterogeneity among arterial endothelial cells , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[28]  Andrea J. Moore,et al.  Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. , 2005, Journal of vascular surgery.

[29]  G. Schmid-Schönbein,et al.  Venous Hypertension and the Inflammatory Cascade: Major Manifestations and Trigger Mechanisms , 2005, Angiology.

[30]  G. Schmid-Schönbein,et al.  An animal model of venous hypertension: the role of inflammation in venous valve failure. , 2005, Journal of vascular surgery.

[31]  A. Eichmann,et al.  Vascular development: from precursor cells to branched arterial and venous networks. , 2005, The International journal of developmental biology.

[32]  M. Detmar,et al.  Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. , 2004, The American journal of pathology.

[33]  G. Oliver,et al.  Choose your fate: artery, vein or lymphatic vessel? , 2004, Current opinion in genetics & development.

[34]  G. Schmid-Schönbein,et al.  Hypertension-induced venous valve remodeling. , 2004, Journal of vascular surgery.

[35]  M. Detmar,et al.  Tumor progression: the effects of thrombospondin-1 and -2. , 2004, The international journal of biochemistry & cell biology.

[36]  L. Horstman,et al.  Endothelial microparticles as markers of endothelial dysfunction. , 2004, Frontiers in bioscience : a journal and virtual library.

[37]  E. Schiffrin,et al.  ETA Receptor Mediates Altered Leukocyte-Endothelial Cell Interaction and Adhesion Molecules Expression in DOCA–Salt Rats , 2004, Hypertension.

[38]  W. R. Taylor,et al.  Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Stimulates an Inflammatory Response* , 2003, Journal of Biological Chemistry.

[39]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[40]  R. Adams.  Molecular control of arterial–venous blood vessel identity , 2003, Journal of anatomy.

[41]  J. Lawler,et al.  Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth , 2002, Journal of cellular and molecular medicine.

[42]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[43]  J. Campos-Ortega,et al.  Notch signaling is required for arterial-venous differentiation during embryonic vascular development. , 2001, Development.

[44]  B. McManus,et al.  A Comparison of Aorta and Vena Cava Medial Message Expression by cDNA Array Analysis Identifies a Set of 68 Consistently Differentially Expressed Genes, All in Aortic Media , 2000, Circulation research.

[45]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[46]  J. Alexander,et al.  Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[47]  C. Kevil,et al.  Expression of Zonula Occludens and Adherens Junctional Proteins in Human Venous and Arterial Endothelian Cells: Role of Occludin in Endothelial Solute Barriers , 1998, Microcirculation.

[48]  J. Dagorn,et al.  The pancreatitis-associated protein is induced by free radicals in AR4-2J cells and confers cell resistance to apoptosis. , 1998, Gastroenterology.

[49]  D. Martin,et al.  Venous tone in the developmental stages of spontaneous hypertension. , 1998, Hypertension.

[50]  R. Schmieder,et al.  Central blood volume: a determinant of early cardiac adaptation in arterial hypertension? , 1995, Journal of the American College of Cardiology.

[51]  H. Friesen,et al.  Molecular cloning and expression of peptide 23, a growth hormone-releasing hormone-inducible pituitary protein. , 1995, Endocrinology.

[52]  J. Swales.  Textbook of hypertension , 1994 .

[53]  P. Hogg,et al.  Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. , 1993, The Journal of biological chemistry.

[54]  K. Ley,et al.  Endothelial, not hemodynamic, differences are responsible for preferential leukocyte rolling in rat mesenteric venules. , 1991, Circulation research.

[55]  M. L. Le Beau,et al.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Safar,et al.  Arterial and venous compliance in sustained essential hypertension. , 1987, Hypertension.

[57]  H. Granger,et al.  Splanchnic circulation in hypertension. , 1983, Federation proceedings.

[58]  D. Young,et al.  Experimental Aldosterone Hypertension in the Dog , 1982, Hypertension.

[59]  S. Ricksten,et al.  Peripheral and central vascular compliances in conscious normotensive and spontaneously hypertensive rats. , 1981, Acta physiologica Scandinavica.

[60]  N. Trippodo,et al.  Decreased total venous capacity in Goldblatt hypertensive rats. , 1981, The American journal of physiology.

[61]  M. Safar,et al.  Total effective compliance of the vascular bed in essential hypertension. , 1978, American heart journal.